C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score

Stroke

Volumn 42, Issue 5, 2011, Pages 1230-1236

  Di Napoli, Mario ^a,b   Godoy, Daniel Agustin ^c   Campi, Veronica ^c   Del Valle, Marta ^d   Piñero, Gustavo ^d   Mirofsky, Matias ^d   Popa Wagner, Aurel ^e   Masotti, Luca ^f   Papa, Francesca ^b   Rabinstein, Alejandro A ^g  

^a San Camillo De' Lellis General Hospital   (Italy)

^b SMDN Center for Cardiovascular Medicine and Cerebrovascular Disease Prevention   (Italy)

^c Sanatorio Pasteur   (Argentina)

^d Hospital Municipal Leonidas Lucero   (Argentina)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f Cecina Hospital   (Italy)

^g MAYO CLINIC   (United States)

Author keywords

acute phase reactants; C reactive protein; intracerebral hemorrhage; leukocytes; prognosis

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CEREBRAL HEMORRHAGE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 79955476510     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.604983     Document Type: Article

References (26)

1. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemor-rhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-2023. (Pubitemid 46850654)
2. Hwang BY, Appelboom G, Kellner CP, Carpenter AM, Kellner MA, Gigante PR, et al. Clinical grading scales in intracerebral hemorrhage. Neurocrit Care. 2010;13:141-151.
3. Wang J, Doré S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894-908. (Pubitemid 46659028)
4. Godoy DA, Di Napoli M, Rabinstein AA. Treating hyperglycemia in neu-rocritical patients: Benefits and perils. Neurocrit Care. 2010;13:425-438.
5. Ali M, Lyden P, Sacco RL, Shuaib A, Lees KR, VISTA investigators. Natural history of complications after intracerebral haemorrhage. Eur J Neurol. 2009;16:624-630.
6. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Sander K, Smith CJ, Stefanini A, Weber D. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke. 2005;36:1316-1329. (Pubitemid 40798763)
7. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W, CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147-1152. (Pubitemid 38543534)
8. Castellanos M, Leira R, Tejada J, Gil-Peralta A, Dávalos A, Castillo J, Stroke Project, Cerebrovascular Diseases Group of the Spanish Neuro-logical Society. Predictors of good outcome in medium to large spon-taneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry. 2005;76:691-695. (Pubitemid 40569680)
9. Castillo J, Dávalos A, Alvarez-Sabín J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS. Molecular signatures ofbrain injury after intrace-rebral hemorrhage. Neurology. 2002;58:624-629. (Pubitemid 34164947)
10. Diedler J, Sykora M, Hahn P, Rupp A, Rocco A, Herweh C, Steiner T. C-reactive-protein levels associated with infection predict short-and long-term outcome after supratentorial intracerebral hemorrhage. Cere-brovasc Dis. 2009;27:272-279.
11. Collier B, Dossett LA, May AK, Diaz JJ. Glucose control and the inflammatory response. Nutr Clin Pract. 2008;23:3-15. (Pubitemid 351438964)
12. Griffiths M, Neal JW, Gasque P. Innate immunity and protective neuro-inflammation: new emphasis on the role of neuroimmune regulatory proteins. Int Rev Neurobiol. 2007;82:29-55.
13. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemor-rhage. Stroke. 2001;32:891-897.
14. Godoy DA, Piñero GR, Svampa S, Papa F, Di Napoli M. Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hem-orrhage. Neurocrit Care. 2008;9:217-229.
15. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-84
16. European Stroke Initiative Writing Committee, Writing Committee for the EUSI Executive Committee, Steiner T, Kaste M, Katse M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W. Recommendations for the management of intracranial haemor-rhage\part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22:294-316.
17. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuc-carello M, Khoury J. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305. (Pubitemid 26286157)
18. Cheung RT, Zou LY. Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke. 2003;34:1717-1722. (Pubitemid 36842633)
19. Janes H, Pepe MS, Gu W. Assessing the value ofrisk predictions by using risk stratification tables. Ann Intern Med. 2008;149:751-760.
20. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker:from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172. (Pubitemid 351193639)
21. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565-574. (Pubitemid 44728772)
22. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenb-roucke JP. The Strengthening the Reporting of Observational Studies in epidemiology (STROBE) statement: guidelines for reporting observa-tional studies. PLoS Med. 2007;4:e296.
23. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat. 2006;100:229-235. (Pubitemid 44631925)
24. Song EC, Chu K, Jeong SW, Jung KH, Kim SH, Kim M, Yoon BW. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke. 2003;34:2215-2220. (Pubitemid 37099839)
25. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-1064. (Pubitemid 39287915)
26. Kimura K, Iguchi Y, Inoue T, Shibazaki K, Matsumoto N, Kobayashi K, Yamashita S. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci. 2007;255: 90-94 (Pubitemid 46414023)